Tofogliflozin
-
Catalog numberB2083-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name(1S,3'R,4'S,5'S,6'R)-6-[(4-Ethylphenyl)methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4',5'-triol; CSG452
-
DescriptionTofogliflozin is a potent, and highly selective SGLT2 inhibitor that has been shown to improve glycemic control in diabetic mice and rats. Potential drug for treatment of type 2 diabetes.
-
CAS Number903565-83-3
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₂H₂₆O₆
-
Molecular Weight386.44
-
Cell PermeableYes
-
Purity≥98%
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA potent sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD27665464
-
PubChem CID46908929
-
SMILESCCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2
-
InChiInChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1
-
InChi KeyVWVKUNOPTJGDOB-BDHVOXNPSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameTofogliflozin
-
Alternative nameTofogliflozin
-